Orange Book product · Generic (ANDA)
IMIPRAMINE HYDROCHLORIDE
IMIPRAMINE HYDROCHLORIDE
At a glance
Oct 21, 1983
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 21, 1983
43 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
IMIPRAMINE HYDROCHLORIDE
Strength
25MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 088262
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of IMIPRAMINE HYDROCHLORIDE
- —TOFRANILBrand (NDA)
NDA 011838 · NOVARTIS
- —JANIMINEBrand (NDA)
NDA 017895 · ABBOTT
- —PRESAMINEBrand (NDA)
NDA 011836 · SANOFI AVENTIS US
- 2012IMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 040903 · LEADING
- 2010IMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 090441 · CHARTWELL
- 2008IMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 040751 · OXFORD PHARMS
- 1990IMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 081048 · SUN PHARM INDUSTRIES
- 1990IMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 081049 · SUN PHARM INDUSTRIES
- 1990IMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 081050 · SUN PHARM INDUSTRIES
- 1987IMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 089422 · PAR PHARM
- 1987IMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 089497 · PAR PHARM
- 1984IMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 087846 · SPECGX LLC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
